Literature DB >> 27909314

Controlled detonation: evolution of necroptosis in pathogen defense.

Michelle Brault1,2, Andrew Oberst1.   

Abstract

Necroptosis is a lytic form of programmed cell death that involves the swelling and rupture of dying cells. Although several necroptosis-inducing stimuli have been defined, in most cells this pathway is kept in check by the action of the pro-apoptotic protease caspase-8 and the IAP ubiquitin ligases. How and when necroptosis is triggered under physiological conditions therefore remains a persistent question. Because necroptosis likely arose as a defensive mechanism against viral infection, exploration of this question requires a consideration of host-pathogen interactions, and how the sensing of infection could sensitize cells to necroptosis. Here, we will discuss the role of necroptosis in the response to viral infection, consider why the necroptotic pathway has been favored during evolution, and describe emerging evidence for death-independent functions of key necroptotic signaling components.

Entities:  

Mesh:

Year:  2016        PMID: 27909314      PMCID: PMC6855669          DOI: 10.1038/icb.2016.117

Source DB:  PubMed          Journal:  Immunol Cell Biol        ISSN: 0818-9641            Impact factor:   5.126


  49 in total

Review 1.  Living with death: the evolution of the mitochondrial pathway of apoptosis in animals.

Authors:  A Oberst; C Bender; D R Green
Journal:  Cell Death Differ       Date:  2008-05-02       Impact factor: 15.828

2.  Induction of necrotic-like cell death by tumor necrosis factor alpha and caspase inhibitors: novel mechanism for killing virus-infected cells.

Authors:  M Li; A A Beg
Journal:  J Virol       Date:  2000-08       Impact factor: 5.103

3.  RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis.

Authors:  S Orozco; N Yatim; M R Werner; H Tran; S Y Gunja; S W G Tait; M L Albert; D R Green; A Oberst
Journal:  Cell Death Differ       Date:  2014-06-06       Impact factor: 15.828

4.  Herpes simplex virus suppresses necroptosis in human cells.

Authors:  Hongyan Guo; Shinya Omoto; Philip A Harris; Joshua N Finger; John Bertin; Peter J Gough; William J Kaiser; Edward S Mocarski
Journal:  Cell Host Microbe       Date:  2015-02-11       Impact factor: 21.023

5.  Staphylococcus aureus degrades neutrophil extracellular traps to promote immune cell death.

Authors:  Vilasack Thammavongsa; Dominique M Missiakas; Olaf Schneewind
Journal:  Science       Date:  2013-11-15       Impact factor: 47.728

Review 6.  Viral modulation of programmed necrosis.

Authors:  William J Kaiser; Jason W Upton; Edward S Mocarski
Journal:  Curr Opin Virol       Date:  2013-06-15       Impact factor: 7.090

7.  RIP1 suppresses innate immune necrotic as well as apoptotic cell death during mammalian parturition.

Authors:  William J Kaiser; Lisa P Daley-Bauer; Roshan J Thapa; Pratyusha Mandal; Scott B Berger; Chunzi Huang; Aarthi Sundararajan; Hongyan Guo; Linda Roback; Samuel H Speck; John Bertin; Peter J Gough; Siddharth Balachandran; Edward S Mocarski
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-12       Impact factor: 11.205

Review 8.  The Drosophila imd signaling pathway.

Authors:  Henna Myllymäki; Susanna Valanne; Mika Rämet
Journal:  J Immunol       Date:  2014-04-15       Impact factor: 5.422

9.  Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3.

Authors:  Huayi Wang; Liming Sun; Lijing Su; Josep Rizo; Lei Liu; Li-Feng Wang; Fu-Sheng Wang; Xiaodong Wang
Journal:  Mol Cell       Date:  2014-04-03       Impact factor: 17.970

10.  Caspase-1-induced pyroptosis is an innate immune effector mechanism against intracellular bacteria.

Authors:  Edward A Miao; Irina A Leaf; Piper M Treuting; Dat P Mao; Monica Dors; Anasuya Sarkar; Sarah E Warren; Mark D Wewers; Alan Aderem
Journal:  Nat Immunol       Date:  2010-11-07       Impact factor: 25.606

View more
  24 in total

Review 1.  Programmed Cell Death and Inflammation: Winter Is Coming.

Authors:  Joseph P Kolb; Thomas H Oguin; Andrew Oberst; Jennifer Martinez
Journal:  Trends Immunol       Date:  2017-07-19       Impact factor: 16.687

2.  Necroptotic death signaling: evolution, mechanisms and disease relevance.

Authors:  James E Vince
Journal:  Immunol Cell Biol       Date:  2017-02       Impact factor: 5.126

3.  Outcomes of RIP Kinase Signaling During Neuroinvasive Viral Infection.

Authors:  Brian P Daniels; Andrew Oberst
Journal:  Curr Top Microbiol Immunol       Date:  2020-04-07       Impact factor: 4.291

Review 4.  RIPK3 in cell death and inflammation: the good, the bad, and the ugly.

Authors:  Susana Orozco; Andrew Oberst
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

Review 5.  Insane in the membrane: a structural perspective of MLKL function in necroptosis.

Authors:  Emma J Petrie; Joanne M Hildebrand; James M Murphy
Journal:  Immunol Cell Biol       Date:  2017-01-17       Impact factor: 5.126

6.  Characterization of Necroptosis-Related Molecular Subtypes and Therapeutic Response in Lung Adenocarcinoma.

Authors:  Jingchen Zhang; Xujian He; Jia Hu; Tong Li
Journal:  Front Genet       Date:  2022-06-08       Impact factor: 4.772

7.  RIPK3 collaborates with GSDMD to drive tissue injury in lethal polymicrobial sepsis.

Authors:  Hui Chen; Yinshuang Li; Jianfeng Wu; Guoping Li; Xuan Tao; Kunmei Lai; Ying Yuan; Xiaohong Zhang; Zhenhuan Zou; Yanfang Xu
Journal:  Cell Death Differ       Date:  2020-03-09       Impact factor: 15.828

8.  Necroptosis: MLKL Polymerization.

Authors:  Andrea Johnston; Zhigao Wang
Journal:  J Nat Sci       Date:  2018-07

Review 9.  Programmed Necrosis and Disease:We interrupt your regular programming to bring you necroinflammation.

Authors:  Eui Ho Kim; Sing-Wai Wong; Jennifer Martinez
Journal:  Cell Death Differ       Date:  2018-10-22       Impact factor: 15.828

Review 10.  Pyroptosis versus necroptosis: similarities, differences, and crosstalk.

Authors:  Daniel Frank; James E Vince
Journal:  Cell Death Differ       Date:  2018-10-19       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.